The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

Authors :: Macaluso FS
Cottone M
Orlando A
Source :: Journal of Crohn's & colitis [J Crohns Colitis] 2016 Dec; Vol. 10 (12), pp. 1451. Date of Electronic Publication: 2016 Apr 28.
Publication Year :: 2016

Subjects :: Drug Therapy, Combination
Humans
Immunologic Factors administration & dosage
Infliximab administration & dosage
Treatment Failure
Immunologic Factors therapeutic use
Inflammatory Bowel Diseases drug therapy
Infliximab therapeutic use

Full Text Access

Tools